Challenges and progress in the development of a serogroup B meningococcal vaccine

被引：3
|
作者：
Lewis, Susan [1 ]
Sadarangani, Manish [1 ]
Hoe, J. Claire [1 ]
Pollard, Andrew J. [1 ]
机构：
[1] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Dept Paediat,Oxford Vaccine Grp, Oxford OX3 7LJ, England
来源：
EXPERT REVIEW OF VACCINES | 2009年 / 8卷 / 06期
关键词：
5CVMB; meningococcal disease; outer membrane protein; outer membrane vesicle vaccine; serogroup B; MEMBRANE-VESICLE VACCINE; INNER-CORE LIPOPOLYSACCHARIDE; MENINGITIDIS GROUP-B; H-BINDING PROTEIN; SYNERGISTIC BACTERICIDAL ACTIVITY; NEISSERIA-LACTAMICA PROTECTS; HUMAN-ANTIBODY RESPONSES; HUMAN SERUM ANTIBODIES; NEW-ZEALAND; ESCHERICHIA-COLI;
D O I：
10.1586/ERV.09.30
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Serogroup B meningococci cause the majority of the meningococcal disease burden in developed countries. Production of an effective and safe vaccine for serogroup B organisms has been hampered by the poor immunogenicity of the capsular polysaccharide that defines this group of bacteria. Previous efforts have focused on outer membrane vesicle vaccines, which have been implemented successfully during clonal outbreaks. However, the search for a universal vaccine against endemic polyclonal serogroup B meningococcal disease continues. In this review, we have highlighted recent development of outer membrane vesicle vaccines and progress in the evaluation of recombinant outer membrane protein vaccines.
引用
收藏
页码：729 / 745
页数：17
相关论文
共 50 条
  • [1] An effective serogroup B meningococcal vaccine
    Dominguez, Francisco
    Menendez, Jorge
    Ochoa, Rolando
    VACCINE, 2006, 24 (49-50) : 7025 - 7026
  • [2] Trumenba: A Serogroup B Meningococcal Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1459): : 5 - 6
  • [3] Bexsero - A Second Serogroup B Meningococcal Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1482): : 158 - 159
  • [4] Adoption of Serogroup B Meningococcal Vaccine Recommendations
    Kempe, Allison
    Allison, Mandy A.
    MacNeil, Jessica R.
    O'Leary, Sean T.
    Crane, Lori A.
    Beaty, Brenda L.
    Hurley, Laura P.
    Brtnikova, Michaela
    Lindley, Megan C.
    Albert, Alison P.
    PEDIATRICS, 2018, 142 (03)
  • [5] Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students
    Holmes, J. D.
    Martin, D.
    Ramsay, C.
    Ypma, E.
    Oster, P.
    EPIDEMIOLOGY AND INFECTION, 2008, 136 (06): : 790 - 799
  • [6] Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine
    Marshall, Gary S.
    Tan, Litjen
    PEDIATRICS, 2017, 139 (05)
  • [7] Inching Toward a Serogroup B Meningococcal Vaccine for Infants
    Cohn, Amanda C.
    Messonnier, Nancy E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (06): : 614 - 615
  • [8] Will booster doses be required for serogroup B meningococcal vaccine?
    McQuaid, Fiona
    Snape, Matthew D.
    EXPERT REVIEW OF VACCINES, 2014, 13 (03) : 313 - 315
  • [9] Recent Progress in the Prevention of Serogroup B Meningococcal Disease
    Feavers, Ian M.
    Maiden, Martin C. J.
    CLINICAL AND VACCINE IMMUNOLOGY, 2017, 24 (05)
  • [10] Over-expression of fHbp in Arabdopsis for development of meningococcal serogroup B subunit vaccine
    Xu, Nuo
    Wang, Yunpeng
    Ma, Jisheng
    Jin, Libo
    Xing, Shaochen
    Jiang, Chao
    Li, Xiaokun
    BIOTECHNOLOGY JOURNAL, 2016, 11 (07) : 973 - 980
12345